Nephrology and Hypertension

Research Faculty

Division HeadHide

Prasad Devarajan, MD Director, Division of Nephrology and Hypertension

Prasad Devarajan, MD, researches acute kidney injury mechanisms, biomarkers and novel therapies. He also studies focal segmental glomerulosclerosis pathogenesis and biomarkers; and lupus nephritis molecular pathways and biomarkers. For each condition, his team employs an integrated approach of genomic and proteomic discovery in animal and human models, followed by translation, and validation in the human disease states.
Visit the Devarajan Research Lab.

513-636-4531 prasad.devarajan@cchmc.org

FacultyShow

Stefanie W. Benoit, MD, MPH Medical Director, Nephrology Clinical Lab

513-636-8647 stefanie.benoit@cchmc.org

Elif Erkan, MD, MS Pediatric Nephrologist, Division of Nephrology

Elif Erkan, MD, MS, is a physician scientist whose research interests are proteinuria induced injury in the kidney and the mechanism of albumin endocytosis in the proximal tubule epithelial cells. Her laboratory studies the protein-protein interactions between endocytic receptors/adapters and protein kinases that are involved in cell signaling events.

513-636-4531 elif.erkan@cchmc.org

Stuart L. Goldstein, MD, FAAP, FNKF Clark D. West Endowed Chair

Stuart L. Goldstein, MD, FAAP, FNKF, focuses on all aspects of acute kidney injury (AKI) spanning from translational work in AKI biomarker validation to long-term AKI epidemiology and outcomes. He is specifically interested in improving outcomes in the critically ill child with or at risk for AKI.

513-636-2078 stuart.goldstein@cchmc.org

David K. Hooper, MD, MS Medical Director of Kidney Transplantation

David K. Hooper, MD, MS, aims to improve clinical outcomes for pediatric kidney transplant recipients through research in personalized care and the design of systems capable of delivering that care with high reliability. His primary focus is the prevention of cardiovascular disease through a combination of quality improvement and clinical/translational research methods.

513-636-4531 nephrology@cchmc.org

Mark M. Mitsnefes, MD, MS Director, Clinical and Translational Research Center

Mark M. Mitsnefes, MD, MS, is an established clinical investigator with expertise in the area of understanding the development of risk factors for cardiovascular disease in children with chronic kidney disease. The long-term goal of his research is to define biologic targets for interventions to prevent and slow progression of cardiovascular disease in children with chronic kidney disease.

513-636-0125 mark.mitsnefes@cchmc.org

Edward J. Nehus, MD, MS Director, Nephrology Fellowship

Edward J. Nehus, MD, MS, is a pediatric nephrologist who has conducted clinical research in chronic kidney disease and critical care nephrology. His primary area of research is studying pharmacokinetic alterations in critically ill children receiving continuous renal replacement therapy. Other research interests include studying cardiovascular risk factors and glomerular filtration rate estimation in children with chronic kidney disease.

513-636-4531 edward.nehus@cchmc.org

C. Frederic Strife, MD

C. Frederic Strife, MD, has focused his research career around immune-mediated renal disease and membranoproliferative glomerulonephritis in particular. Furthermore, Dr. Strife also has been active in understanding how to improve the care of the pediatric dialysis patient.

fred.strife@cchmc.org

Nephrology and Hypertension

Research Faculty

Connect With Us